Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Ophthalmology
Published in: International Ophthalmology 1/2021

01-01-2021 | Coronavirus | Review

Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye

Authors: Eman Al-Sharif, Diego Strianese, Nada H. AlMadhi, Antonella D’Aponte, Roberto dell’Omo, Rita Di Benedetto, Ciro Costagliola

Published in: International Ophthalmology | Issue 1/2021

Login to get access

Abstract

Purpose

Several studies have reported conflicting results on ocular manifestations and transmission of coronavirus disease 2019 (COVID-19) whose causative virus, SARS-CoV-2, belongs to the coronavirus family, the seventh recognized as a human pathogen and the third causing a severe clinical syndrome. COVID-19 primarily affects the lungs, similar to the other human coronaviruses. Comparing the relation between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-Cov-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye may contribute to determining their actual eye-tissue tropism and risk of ocular transmission.

Methods

Literature review was conducted via Pubmed.gov, Google Scholar and medRixv using the following keywords: COVID-19, SARS-CoV-2, SARS-CoV-1, MERS-CoV, CoV-229E, NL63, OC43, HKU1, conjunctivitis, tear swab, ocular expression, ocular symptoms and human angiotensin converting enzyme-2 expression. Studies with lack in methodology were excluded.

Results

Sixteen observational studies were selected. The range for detection of viral RNA in tears was 0–8% for SARS-CoV-1 and 0–5.3% for SARS-CoV-2, while no reports were found for other coronaviruses. Ocular manifestations have been reported for NL63 and SARS-CoV-2. Ocular symptoms in the form of conjunctivitis/conjunctival congestion predominantly were detected in 65 (3.17%) out of 2048 reported patients with COVID-19 (range of 0.8–32%). Eye symptoms were not reported for the other coronaviruses.

Conclusions

Data aggregation for coronaviruses shows a relatively low eye-tissue tropism. Conjunctival congestion is an uncommon manifestation of COVID-19 similar to all human coronaviruses’ infections. In a low percentage of patients, the virus can be excreted in ocular fluids at different stages of the infection, regardless of positive SARS-Cov-2 throat swab. Albeit high viral loads in ocular tissue seem to have relatively low prevalence, the eye should be regarded as a potential source of infection dissemination for COVID-19.
Literature
1.
2.
Peiris JSM (2003) The severe acute respiratory syndrome. N Engl J Med 349:2431–2441PubMed
3.
Zaki AM, van Boheemen S, Bestebroer TM et al (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820PubMed
4.
Zhou P, Yang X-L, Wang X-G et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273PubMedPubMedCentral
5.
Parrish RK, Stewart MW, Duncan Powers SL (2020) ophthalmologists are more than eye doctors—in memoriam Li Wenliang. Am J Ophthalmol 213:A1–A2PubMedPubMedCentral
6.
7.
8.
Leong HN, Chan KP, Khan AS et al (2004) Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital. Emerg Infect Dis 10:1745–1750PubMedPubMedCentral
9.
Yuen KSC, Chan W-M, Fan DSP et al (2004) Ocular screening in severe acute respiratory syndrome. Am J Ophthalmol 137:773–774PubMedPubMedCentral
10.
11.
12.
Xia J, Tong J, Liu M et al (2020) Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 92:589–594 jmv.25725PubMed
13.
14.
Yu Jun IS, Anderson DE, Zheng Kang AE et al (2020) Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology S0161642020303110
15.
Guan W, Ni Z, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720PubMed
16.
17.
18.
19.
Zhou Y, Duan C, Zeng Y et al (2020) Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology 127:982–983PubMed
20.
21.
Cheema M, Aghazadeh H, Nazarali S et al (2020) Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol, S0008418220303057
22.
WHO. WHO announces COVID-19 outbreak a pandemic. 3 November 2020
23.
24.
Esper F, Shapiro ED, Weibel C et al (2005) Association between a novel human coronavirus and kawasaki disease. J Infect Dis 191:499–502PubMed
25.
26.
Fung TS, Liu DX (2019) Human coronavirus: host-pathogen interaction. Annu Rev Microbiol 73:529–557PubMed
27.
Yin Y, Wunderink RG (2018) MERS, SARS and other coronaviruses as causes of pneumonia: MERS SARS and coronaviruses. Respirology 23:130–137PubMed
28.
29.
Woo PCY, Lau SKP, Chu C-M et al (2005) Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79:884–895PubMedPubMedCentral
30.
van der Hoek L (2007) (2007) Human coronaviruses: what do they cause? Antivir Ther 12(4B):651–658PubMed
31.
Ithete NL, Stoffberg S, Corman VM et al (2013) Close relative of human middle east respiratory syndrome coronavirus in Bat South Africa. Emerg Infect Dis 19:1697–1699PubMedPubMedCentral
32.
Wang L-F, Eaton BT (2007) Bats, civets and the emergence of SARS. In: Childs JE, Mackenzie JS, Richt JA (eds) Wildlife and emerging zoonotic diseases: the biology, circumstances and consequences of cross-species transmission. Springer, Berlin, pp 325–344
33.
Guo Y-R, Cao Q-D, Hong Z-S et al (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Military Med Res 7:11
34.
Li W, Moore MJ, Vasilieva N et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454PubMedPubMedCentral
35.
Holappa M (2015) Ocular renin-angiotensin system with special reference in the anterior part of the eye. WJO 5:110
36.
Senanayake PD, Drazba J, Shadrach K et al (2007) Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci 48:3301PubMed
37.
Sun Y, Liu L, Pan X, Jing M (2006) Mechanism of the action between the SARS-CoV S240 protein and the ACE2 receptor in eyes. Int Ophthalmol 6:783–786
38.
Meyerholz DK, Lambertz AM, McCray PB (2016) Dipeptidyl peptidase 4 distribution in the human respiratory tract. Am J Pathol 186:78–86PubMedPubMedCentral
39.
Robbins SG, Detrick B, Hooks JJ (1990) Retinopathy following intravitreal injection of mice with MHV strain JHM. Adv Exp Med Biol 276:519–524PubMed
40.
Robbins SG, Derrick B (1991) Ocular tropisms of murine coronavirus (strain JHM) after inoculation by various routes. Investig Ophthamol Vis Sci 32:1883–1893
41.
Hooks JJ, Percopo C, Wang Y et al (1993) Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy. J Immunol 151:3381PubMed
42.
Hooper LC, Chin MS, Detrick B et al (2005) Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-α, soluble TNFR2 and altered TNF-α signaling. J Neuroimmunol 166:65–74PubMedPubMedCentral
43.
Neri P, Pichi F (2020) COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Int Ophthalmol 40:1057–1060PubMedPubMedCentral
44.
45.
46.
Loon SC, Lun K (2013) SARS: a timely reminder. Br J Ophthalmol 97:1217–1218PubMed
47.
48.
Hui KPY, Cheung M-C, Perera RAPM et al (2020) Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med S2213260020301934
49.
Alonso WJ, Nascimento FC, Shapiro J et al (2013) Facing ubiquitous viruses: when hand washing is not enough. Clin Infect Dis 56:617–617PubMedPubMedCentral
50.
51.
52.
Arabi YM, Arifi AA, Balkhy HH et al (2014) Clinical course and outcomes of critically ill patients with middle east respiratory syndrome coronavirus infection. Ann Intern Med 160:389–397PubMed
53.
Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan China. JAMA 323:1061PubMedPubMedCentral
54.
Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China The Lancet 395:497–506
55.
56.
Ajlan AM, Ahyad RA, Jamjoom LG et al (2014) Middle east respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. Am J Roentgenol 203:782–787
57.
Alfaraj SH, Al-Tawfiq JA, Altuwaijri TA et al (2019) Middle east respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia. Front Med 13:126–130PubMed
58.
Cunha CB, Opal SM (2014) Middle east respiratory syndrome (MERS): a new zoonotic viral pneumonia. Virulence 5:650–654PubMedPubMedCentral
59.
Li JPO, Lam DSC, Chen Y et al (2020) Novel Coronavirus disease 2019 (COVID-19): the importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol 104:297–298PubMed
60.
Lancet T (2020) COVID-19: protecting health-care workers. Lancet 395:922
61.
62.
63.
64.
Michael Burdon. The Royal College of Ophthalmologists Protecting Patients, Protecting Staff. The Royal College of Ophthalmologists, 30 March 2020
65.
Seto W, Tsang D, Yung R et al (2003) Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 361:1519–1520PubMedPubMedCentral
66.
Suwantarat N, Apisarnthanarak A (2015) Risks to healthcare workers with emerging diseases: lessons from MERS-CoV, Ebola, SARS, and avian flu. Curr Opin Infect Dis 28:349–361PubMed
67.
China National Health Commission. Announcement of national health commission of the people’s republic of China. http://​wwwnhcgovcn/​jkj/​s7916/​202001/​44a3 b8245e8049d2837a4f27529cd386shtml. Accessed 20 Jan 2020
68.
Chang D, Xu H, Rebaza A et al (2020) Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med 8:e13PubMedPubMedCentral
69.
Luo S-H, Liu W, Liu Z-J et al (2020) A confirmed asymptomatic carrier of 2019 novel coronavirus (SARS-CoV-2). Chin Med J 133:1123–1125PubMedPubMedCentral
70.
71.
Day M (2020) Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ
72.
73.
74.
75.
Rabenau HF, Kampf G, Cinatl J et al (2005) Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect 61:107–111PubMedPubMedCentral
76.
77.
Tran K, Cimon K, Severn M et al (2012) Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS ONE 7:e35797PubMedPubMedCentral
78.
Metadata
Title
Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye
Authors
Eman Al-Sharif
Diego Strianese
Nada H. AlMadhi
Antonella D’Aponte
Roberto dell’Omo
Rita Di Benedetto
Ciro Costagliola
Publication date
01-01-2021
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 1/2021
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-020-01575-2

Other articles of this Issue 1/2021

International Ophthalmology 1/2021 Go to the issue

Original Paper

Comparison of vessel density in macular and peripapillary regions between primary open-angle glaucoma and pseudoexfoliation glaucoma using OCTA

Original Paper

Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a Tertiary Eye Care Institute in India

Original Paper

Comparison between aberration-free transepithelial photorefractive keratectomy and small incision lenticule extraction for correction of myopia and myopic astigmatism

Original Paper

Is optical coherence tomography angiography a useful tool in the screening of hydroxychloroquine retinopathy?

Original Paper

Pars plana vitrectomy for posteriorly dislocated intraocular lenses: risk factors and surgical approach

Original Paper

Molecular and clinical characterization of Thai patients with achromatopsia: identification of three novel disease-associated variants in the CNGA3 and CNGB3 genes